Document Detail


Pharmacokinetics of propofol and its conjugates after continuous infusion in normal and in renal failure patients: a preliminary study.
MedLine Citation:
PMID:  8310787     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
The pharmacokinetics of propofol, 2,6 diisopropylphenol, were compared in 6 end-stage renal failure patients aged 66.3 +/- 12.1 years and in 5 normal patients aged 45.5 +/- 13.5 years. Anesthesia was induced with propofol (2 and 2.5 mg.kg-1 respectively) and fentanyl (0.1 mg). Anesthesia was maintained with propofol (9 and 10 mg.kg-1 x h-1 respectively). Patients breathed spontaneously a 50 per cent oxygen in nitrous oxide mixture. Two ml blood samples were taken during anesthesia and at regular intervals until up to 24 hours after infusion. Plasma levels of propofol were determined by HPLC with electrochemical detection. Propofol conjugates were determined after hydrolysis with beta glucuronidase or HCl. Results were expressed as median [lower-upper percentiles]. Propofol clearance (1.53 [1.02-2.10] L.min-1 x kg-1 versus 1.65 [1.39-1.78] L.min-1 x kg-1 in normal patients), and half-lives elimination were not modified by renal failure. Renal failure patients exhibited a higher volume of distribution at steady state as compared to normal patients (19.28 [11.71-76.81] L.kg-1 versus 8.60 [6.58-9.81] L.kg-1, p < 0.05). Renal failure did not affect the production of conjugates but they accumulated in blood of renal failure patients. Despite this, no difference in time to eyes opening and propofol concentration were observed, confirming the absence of clinical effect of these metabolites.
Authors:
N Nathan; J Debord; F Narcisse; J L Dupuis; M Lagarde; D Benevent; G Lachatre; P Feiss
Related Documents :
9392807 - Efficacy and safety of a new protocol for continuous infusion of midazolam and fentanyl...
23884727 - Lung ultrasound during hemodialysis: the role in the assessment of volume status.
15488087 - Safety of dobutamine stress transesophageal echocardiography in obese patients for eval...
7650257 - The use of propofol for sedation of critically ill patients undergoing haemodiafiltration.
6394127 - Comparative evaluation of netilmicin-ticarcillin and tobramycin-ticarcillin in the trea...
9392807 - Efficacy and safety of a new protocol for continuous infusion of midazolam and fentanyl...
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Acta anaesthesiologica Belgica     Volume:  44     ISSN:  0001-5164     ISO Abbreviation:  Acta Anaesthesiol Belg     Publication Date:  1993  
Date Detail:
Created Date:  1994-03-17     Completed Date:  1994-03-17     Revised Date:  2004-11-17    
Medline Journal Info:
Nlm Unique ID:  0421022     Medline TA:  Acta Anaesthesiol Belg     Country:  BELGIUM    
Other Details:
Languages:  eng     Pagination:  77-85     Citation Subset:  IM    
Affiliation:
Department of Pharmacology and Toxicology, CHU Dupuytren, Limoges, France.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adult
Aged
Chromatography, High Pressure Liquid
Female
Glucuronidase / metabolism
Half-Life
Humans
Hydrolysis
Kidney Failure, Chronic / metabolism*
Male
Middle Aged
Propofol / blood,  pharmacokinetics*
Chemical
Reg. No./Substance:
2078-54-8/Propofol; EC 3.2.1.31/Glucuronidase

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Incidence of nosocomial pneumonia in ICU patients.
Next Document:  Opioid receptors-mediated respiratory effects and antinociception after S(+)-ketamine.